STING1 and systemic lupus erythematosus: The recent identification that mutations in STING or TREX1 (which both work to regulate IFN-β production) drive monogenic forms of IFN-driven disease (interferonopathies) have suggested that dysregulation of these pathways may contribute to interferon driven diseases such as SLE or Sjogren's syndrome (98).